CONTEXT: Market report on the still buoyant RWE market, or at least the valuations of the market are buoyant | Different day, different figure IMPACT: Low READ TIME: 1 min Continue Reading
CONTEXT: Early days in this incredibly worth while endeavour to use the newly emerging AI/ML tools to process patient data into research grade data. Created within this cholangiocarcinoma (bile duct Continue Reading
CONTEXT: They say cancer is the great leveller. Apparently not. This is a well put together, thought-provoking article highlighting the inequalities in cancer treatments and how RWR can help even Continue Reading
CONTEXT: Hopefully this report is not the last we will see or hear of the Pistoia Alliance. Bringing the industry together to break down barriers for data sharing on the Continue Reading
CONTEXT: Fascinating report on research looking at ways to improve the way we can use retrospective data and help avoid selection bias. Using increasingly sophisticated methods to look at all Continue Reading
CONTEXT: Announcement of a significant piece of research looking at NSCLC across three study types and involving 12,000 patients. This type of big ambition research will no doubt yield significant Continue Reading
CONTEXT: Report of a retrospective analysis of direct oral anticoagulants showing they are safer and more effective than warfarin. IMPACT: Low READ TIME: 2 mins Quality Level Mean [1 – Continue Reading
CONTEXT: Peer reviewed literature review of methotrexate auto-injectors predominantly in RA | Interesting that despite the huge datasets involved in this research, it can come down to whether or not the Continue Reading
CONTEXT: This peer reviewed report on an open label extension to a pivotal ADHD study wouldn’t normally get out attention, but the treatment of kids using digital tech had us Continue Reading
CONTEXT: Opinion piece on where the author sees the FDA being focused through this next year. IMPACT: Low READ TIME: 2 mins Quality Level Mean [1 – 10]: 6 1. Continue Reading
